Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions

Zoltan Beck, Bruce K. Brown, Lindsay Wieczorek et al. · 2009

Read Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions by Zoltan Beck, Bruce K. Brown, Lindsay Wieczorek et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008297.txt.

Introduction

Zoltan Beck and colleagues studied red blood cells and HIV in a PLOS ONE paper from 2009. CD4 cells are the major target of HIV infection in blood. Claims that HIV-1 also binds red blood cells had generated controversy. The Duffy blood group antigen was proposed as the binding site. Binding without complement proteins was part of the dispute.

The team examined the question directly with infectious virus. Human erythrocytes selectively bound and enriched infectious HIV-1 virions. If red cells carry virus, they could shape how HIV spreads in the body. The finding reopens a debated part of HIV biology.

Catalog record

CREATORZoltan Beck, Bruce K. Brown, Lindsay Wieczorek et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE37 KB
LICENSECreative Commons CC0 License
RIGHTSCC0
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008297

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Human Erythrocytes Selectively Bind and Enrich Infectious HIV-1 Virions Authors: Zoltan Beck, Bruce K. Brown, Lindsay Wieczorek, Kristina K. Peachman, Gary R. Matyas, Victoria R. Polonis, Mangala Rao, Carl R. Alving Published: 2009, PLOS ONE DOI: 10.1371/journal.pone.0008297 ABSTRACT Although CD4(+) cells represent the major target for HIV infection in blood, claims of complement-independent binding of HIV-1 to erythrocytes and the possible role of Duffy blood group antigen, have generated controversy. To examine the question of binding to erythrocytes, HIV-1 was incubated in vitro with erythrocytes from 30 healthy leukapheresis donors, and binding was determined by p24 analysis and adsorption of HIV-1 with reduction of infectivity for CD4(+) target cells. All of the cells, regardless of blood group type, bound HIV-1 p24. A typical preparation of erythrocytes bound <2.4% of the added p24, but erythrocytes selectively removed essentially all of the viral infectivity as determined by decreased infection of CD4(+) target cells; however, cell-associated HIV-1 was approximately 100-fold more efficient, via trans infection, than unadsorbed virus for infection of CD4(+) cells. All of the bound HIV-1 p24 was released by treatment of the cells with EDTA, and binding was optimized by adding Ca 2+ and Mg 2+ during the washing of erythrocytes containing bound HIV-1. Although the small number of contaminating leukocytes in the erythrocyte preparation also bound HIV-1 p24, there was no significant binding to CD4, and it thus appears that the binding occurred on leukocytes at non-CD4 sites. Furthermore, binding occurred to erythrocyte ghosts from which contaminating leukocytes had been previously removed. The results demonstrate that erythrocytes incubated in vitro with HIV-1 differentially adsorb all of the infectious HIV-1 virions (as opposed to non-infectious or degraded virions) in the absence of complement and independent of blood group, and binding is dependent on divalent cations. By analogy with HIV-1 bound to DC-SIGN on dendritic cells, erythrocyte-bound HIV-1 might comprise an important surface reservoir for trans infection of permissive cells. INTRODUCTION Upon initial entry into blood, HIV-1 is faced with three major options: (a) directly infect a CD4(+) target cell; (b) remain as a circulating free virion while it searches for a target cell; or (c) temporarily bind to the surface of a CD4(−) cell, such as a circulating dendritic cell, as a depot for infection by transfer of the virus (infection in trans ) to a CD4(+) cell [1] . Infection of a CD4(+) target cell is the goal to which the other two options are directed, but it is also the most difficult to achieve because CD4(+) cells are relatively rare when compared to other circulating cells in the blood. Although free infectious HIV-1 is widely thought to be a major form of the virus in blood [1] , remaining as a free virion is also fraught with danger because of exposure to numerous humoral and cellular defense mechanisms, such as antibodies, complement, or NK cells available to the host [2] – [6] . Calcium-dependent binding of HIV-1 to DC-SIGN on dendritic cells can also occur, and HIV-1 attached to dendritic cells might be protected for more than 4 days either from degradation or neutralization by certain antibodies, when compared to free HIV-1 [7] , [8] . Although trans infection of CD4(+) cells by HIV-1-bound dendritic cells has also been proposed based on in vitro experiments, direct in trans infection has not yet been demonstrated to occur in vivo [9] , and dendritic cells are relatively rare when compared to other circulating blood cells. Claims by several groups that HIV-1 also binds to erythrocytes [10] – [13] have generated controversy. Erythrocytes derived from infected patients were reported to contain cell-bound HIV-1, and erythrocytes were hypothesized to represent a novel viral reservoir [12] , [14] , but erythrocyte-bound HIV-1 from infected patients was subsequently disputed and the reservoir hypothesis was challenged [15] . It was subsequently concluded that erythrocytic complement receptor type 1 (CR1) was responsible for essentially all of the binding of HIV-1 to the erythrocytes [16] . Binding to the erythrocytic blood group Duffy antigen receptor for chemokines (DARC) was also reported [10] , [13] , but claims that DARC mediated genetic tendencies to HIV-1 infection and AIDS [13] , [17] – [19] were strongly challenged [20] – [23] . If erythrocytes are major, or even minor, HIV-1 binding sites not mediated by effectors such as antibodies or complement, this could represent a novel mechanism for transmission of infectious HIV-1 virions to CD4(+) cells in blood. If HIV-1 bound to erythrocytes represents a hidden infectious depot of HIV-1 in vivo , this might also present new challenges for development of broadly neutralizing antibodies for a vaccine. In view of the importance and the controversial nature of the issue of HIV-1 binding to erythrocytes, we examined the binding of HIV-1 both to human erythrocytes and to highly purified erythrocytic ghosts in order to ascertain the degree, if any, that infectious HIV-1 virions bind to erythrocytes in the absence of antibodies or complement, and to shed light on possible implications of such binding for concepts of HIV-1 pathogenesis and mechanisms of transmission for uptake and infection of CD4(+) cells. Our results demonstrate that although a mean of only 2.3% of added HIV-1 p24 became bound to erythrocytes, adsorption with the cells differentially removed nearly all of the infectious virions. The erythrocyte-bound HIV-1 was then approx 100-fold more infectious, via trans infection, for infection of CD4(+) target cells, and the cell-bound HIV-1 reconstituted essentially all of the infectivity of the original unadsorbed free virus. RESULTS After incubation of increasing concentrations of a typical preparation of erythrocytes with HIV-1, followed by washing of the cells, dose-related binding of HIV-1 p24 was observed ( Fig. 1A ). At the highest concentration (8,486 pg of p24, corresponding to a 1∶1 dilution of the viral stock with phenol red-free RPMI), a plateau of binding was still not apparent. However, when 8,486 pg of HIV-1 was then incubated with increasing numbers of erythrocytes, nearly a four-fold increase of p24 binding occurred, resulting in 320 pg of p24 bound per 20×10 7 erythrocytes ( Fig. 1B ). Although a definitive plateau of binding was not quite achieved, the change of slope at high numbers of cells indicated that only a very shallow dose response occurred at the high end of the curve. Thus, in the experiment illustrated only 3.7% of the total p24 added became bound to the cells. Erythrocyte preparations obtained from 30 different donors bound a mean of 2.32% (range 0.03–6.02%), of added p24 of undiluted virus stock incubated with the indicated number of erythrocytes ( Table 1 ). Within this small range of binding, the ratio of added cells/viral p24 bore little exact resemblance to the % of p24 bound with different donor cells. Although erythrocytes from each donor preparation did bind HIV-1, the number of individual samples tested was too small to determine contributing effects, if any, of each potential variable (such as blood group type, or viral clade, or type of co-receptor used by the virus) shown in Table 1 . Although the exact mechanism of binding of the HIV-1 virions to the cells is not yet known, Fig. 2A demonstrates that the binding was completely eliminated in the presence of EDTA.

Read the complete text